Related Experiment Videos
Abstract:
Mouse red blood cells (RBCs) infected with the malaria parasite Plasmodium yoelii nigeriensis were shown to synthesize a histidine-rich protein (His-RP) in vitro. The existence of this protein was demonstrated by comparing fluorograms of infected red blood cells (IRBCs) labelled with either [14C]histidine or [14C]leucine. The molecular weight of this His-RP was estimated to be 43,500, which compares well with the values reported for the avian parasite P. lophurae (45,000) and for the human parasite P. falciparum (42,000). This result supports the idea that such a protein may play an important role in the biology of all plasmodium species.
Insights
Researchers identified a histidine-rich protein (His-RP) synthesized by malaria-infected mouse red blood cells (RBCs). This finding suggests a conserved role for His-RP across Plasmodium species.
Area of Science:
- Malariology
- Parasitology
- Molecular Biology
Background:
- The malaria parasite Plasmodium causes significant global health burdens.
- Understanding parasite biology is crucial for developing new treatments.
Purpose of the Study:
- To investigate the synthesis of specific proteins by Plasmodium yoelii nigeriensis within mouse red blood cells.
- To characterize a novel histidine-rich protein (His-RP) in infected red blood cells (IRBCs).
Main Methods:
- In vitro culture of infected red blood cells (IRBCs).
- Metabolic labeling of IRBCs with [14C]histidine and [14C]leucine.
- Analysis of protein synthesis using fluorography.
Main Results:
- Demonstrated de novo synthesis of a histidine-rich protein (His-RP) in P. yoelii nigeriensis-infected mouse RBCs.
- Estimated the molecular weight of His-RP to be approximately 43,500 Da.
- Observed similar molecular weights for His-RP in avian (P. lophurae) and human (P. falciparum) malaria parasites.
Conclusions:
- The histidine-rich protein (His-RP) is conserved across different Plasmodium species.
- His-RP likely plays a significant role in the biology of Plasmodium parasites.
- Further research into His-RP could reveal new therapeutic targets.